AP23573
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for AP23573, covering 2015-02-19 to 2015-08-27. Get the full timeline:
Most recent: Clinical Trial Update: Safety Study of AP23573 in Patients With Advanced, Refractory or Recurrent Malignancies (8669-013)(COMPLETED) [Phase 1]